欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2517/001
药品名称MAXIVALEN
活性成分
    • fish oil, rich in omega 3-acids 30.0 mg/ml
    • medium-chain triglycerides 60.0 mg/ml
    • OLIVE OIL 50.0 mg/ml
    • SOYBEAN OIL 60.0 mg/ml
剂型Emulsion for infusion
上市许可持有人Noridem Enterprises Ltd
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Germany (DE)
      MAXIVALEN 200 mg/ml Emulsion zur Infusion
    • Hungary (HU)
    • Denmark (DK)
      Maxivalen
    • Czechia (CZ)
      MAXIVALEN
    • Belgium (BE)
      Ziremilon 200 mg/ml émulsion pour perfusion
    • Romania (RO)
      MAXIVALEN 200 mg/ml emulsie perfuzabilă
    • Ireland (IE)
    • Slovakia (SK)
    • Austria (AT)
许可日期2025/07/09
最近更新日期2025/08/26
药物ATC编码
    • B05BA02 fat emulsions
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase